Targeting BRD4 attenuates the stemness and aggressiveness of ameloblastoma.

Oral diseases(2023)

引用 0|浏览6
暂无评分
摘要
BRD4 increases the aggressiveness and promotes the recurrence of ameloblastoma by regulating the Wnt pathway and stemness-associated pathways. These findings highlight BRD4 as a promising therapeutic target in AM management.
更多
查看译文
关键词
ameloblastoma, BRD4, tumorigenesis, Wnt pathway
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要